Search details
1.
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.
Cell
; 184(16): 4203-4219.e32, 2021 08 05.
Article
in English
| MEDLINE | ID: mdl-34242577
2.
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
Cell
; 182(4): 812-827.e19, 2020 08 20.
Article
in English
| MEDLINE | ID: mdl-32697968
3.
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.
N Engl J Med
; 386(11): 1088-1091, 2022 03 17.
Article
in English
| MEDLINE | ID: mdl-35081298
4.
Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase.
PLoS Biol
; 14(12): e1002584, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27935939
5.
Discovery of a novel and potent class of anti-HIV-1 maturation inhibitors with improved virology profile against gag polymorphisms.
Bioorg Med Chem Lett
; 27(12): 2689-2694, 2017 06 15.
Article
in English
| MEDLINE | ID: mdl-28454672
6.
Mapping SARS-CoV-2 antigenic relationships and serological responses.
bioRxiv
; 2023 Jun 16.
Article
in English
| MEDLINE | ID: mdl-35860221
7.
Mapping SARS-CoV-2 antigenic relationships and serological responses.
Science
; 382(6666): eadj0070, 2023 10 06.
Article
in English
| MEDLINE | ID: mdl-37797027
8.
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial.
Sci Transl Med
; 15(692): eade9078, 2023 04 19.
Article
in English
| MEDLINE | ID: mdl-37075127
9.
Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial.
Viruses
; 15(10)2023 09 29.
Article
in English
| MEDLINE | ID: mdl-37896806
10.
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
Science
; 375(6576): 43-50, 2022 Jan 07.
Article
in English
| MEDLINE | ID: mdl-34812653
11.
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines.
bioRxiv
; 2021 Jan 29.
Article
in English
| MEDLINE | ID: mdl-33532764
12.
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines.
Cell Host Microbe
; 29(4): 529-539.e3, 2021 04 14.
Article
in English
| MEDLINE | ID: mdl-33705729
13.
Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation.
medRxiv
; 2021 Sep 14.
Article
in English
| MEDLINE | ID: mdl-34545372
14.
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization.
Cell Host Microbe
; 29(1): 23-31.e4, 2021 01 13.
Article
in English
| MEDLINE | ID: mdl-33306985
15.
Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation.
Sci Rep
; 11(1): 23921, 2021 12 14.
Article
in English
| MEDLINE | ID: mdl-34907214
16.
Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation.
Res Sq
; 2021 Sep 02.
Article
in English
| MEDLINE | ID: mdl-34494017
17.
The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates.
bioRxiv
; 2021 Feb 18.
Article
in English
| MEDLINE | ID: mdl-33442694
18.
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.
Nat Commun
; 12(1): 6097, 2021 10 20.
Article
in English
| MEDLINE | ID: mdl-34671037
19.
Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization.
medRxiv
; 2021 Dec 20.
Article
in English
| MEDLINE | ID: mdl-34931200
20.
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial.
medRxiv
; 2021 Aug 15.
Article
in English
| MEDLINE | ID: mdl-34401888